Monday, September 10, 2007

Merck rewarded the brave

From the Financial Post:
Merck & Co. Inc. suffered through some dark days a few years ago, soon after it faced the prospect of battling an onslaught of 28,000 lawsuits connected to its now-withdrawn Vioxx painkiller. Turns out, those dark days presented investors with one of the best moments in the past decade to buy this top-rate pharmaceutical giant.

The lesson? Once again, it shows that the best time to invest in a company is when it is on the ropes -- an observation that should prove useful to investors as they sift through some of today's most battered stocks and stock market sectors.

Merck hit the ropes about three years ago, when it withdrew Vioxx from the market after a study showed the drug was linked to higher rates of heart attacks and strokes. ...more

No comments: